S Bingyi1, Q Yeyong, C Ming, M Chunbai, Z Wenqiang. Show Affiliations » 1. Department of Urology, Professor and Director, Hospital of PLA, Beijing, China.
Abstract
Mesh： See more » AdultDrug Therapy, CombinationFemaleGraft Rejection/epidemiologyGraft Rejection/prevention & controlHumansImmunosuppressive Agents/adverse effectsImmunosuppressive Agents/therapeutic useInfusions, IntravenousKidney Function TestsKidney Transplantation/immunologyKidney Transplantation/physiologyMaleMiddle AgedPlacebosPostoperative PeriodRecombinant Fusion Proteins/administration & dosageRecombinant Fusion Proteins/adverse effectsRecombinant Fusion Proteins/therapeutic useTime FactorsTransplantation, Homologous
Substances： See more » Immunosuppressive AgentsPlacebosRecombinant Fusion Proteins
Year: 2003 PMID： 12591362 DOI： 10.1016/s0041-1345(02)03769-7
Source DB: PubMed Journal: Transplant Proc ISSN： 0041-1345 Impact factor: 1.066